Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins Envision from Clario, a global clinical trial endpoint and technology ...
Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...
A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...
Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
How do we translate individual experiences into support that helps others and create support that feels personal but remains ...
Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...
Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results